£111.90

This is the most expensive it has ever been. Walk away.

£112 today · previous high £112 · all-time low £108

Springer Advances in Biology and Therapy of Multiple Myeloma Volume 2

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 81 days · 81 data points (no recent data)

Historical
Generating forecast…
£111.90 £107.62 £108.55 £109.49 £110.42 £111.36 £112.29 25 July 2026 14 August 2026 03 September 2026 23 September 2026 13 October 2026
View at Amazon ↗

Price data last checked 10 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price
Current Price
73 days 8 days · current 0 18 37 55 73 £108 £112 Days at Price

Price Analysis

Most common price: £108 (73 days, 90.1%)

Price range: £108 - £112

Price levels: 2 different prices over 81 days

Description

Advances in Biology and Therapy of Multiple Myeloma: Volume 2 explores translational and clinical research strategies for overcoming resistance to current multiple myeloma treatments. This comprehensive Springer publication examines molecularly-based combination therapies and novel biologically-based treatment approaches designed to achieve durable responses in patients. The volume focuses on recent advances in genomics and proteomics, providing oncology professionals and medical researchers with evidence-based insights into developing next-generation therapeutic strategies. Essential reading for healthcare practitioners in internal medicine and oncology seeking to understand emerging approaches to multiple myeloma management and patient outcomes.

Key Features

Springer publication specialising in translational and clinical research on multiple myeloma treatment strategies.

Explores novel biologically-based treatment approaches and molecularly-based combination therapies for improving patient outcomes.

Covers recent advances in genomics and proteomics relevant to multiple myeloma research and therapy development.

Volume 2 in the Advances in Biology and Therapy of Multiple Myeloma series, providing in-depth medical knowledge.

Designed for healthcare practitioners, oncologists and researchers in internal medicine and disease management.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
06 December 2012
Listed Since
14 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 12 Aug 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£80.67 24 Sep 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
98% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£148.94 14 Aug 2026
Treatment of Multiple Myeloma and Related Disorders
98% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 17 Sep 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
98% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 11 Sep 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
98% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£92.80 25 Sep 2026
Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
97% match

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£130.52 15 Aug 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£73.48 13 Oct 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.27 13 Aug 2026
Multiple Myeloma & Plasma Cell Neoplasms Clinical Guide
97% match

Multiple Myeloma & Plasma Cell Neoplasms Clinical Guide

Springer

£111.67 08 Oct 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
97% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£61.58 23 Sep 2026
Horizons in Cancer Research. Volume 73: Volume 73
97% match

Horizons in Cancer Research. Volume 73: Volume 73

£112.65 15 Aug 2026
Contemporary Management of Multiple Myeloma
97% match

Contemporary Management of Multiple Myeloma

Jaypee Brothers Medical Publishers

£39.79 22 Sep 2026
Recent Updates on Multiple Myeloma
97% match

Recent Updates on Multiple Myeloma

IntechOpen

£119.00 24 Sep 2026
Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
97% match

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Springer

£140.60 14 Aug 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
97% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Elsevier

£167.99 22 Aug 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
96% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£104.67 24 Sep 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
96% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£80.64 08 Sep 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.11 12 Sep 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.11 04 Oct 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
96% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£83.26 09 Oct 2026
Genetic and Molecular Epidemiology of Multiple Myeloma
96% match

Genetic and Molecular Epidemiology of Multiple Myeloma

Springer

£79.69 08 Sep 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£144.43 20 Aug 2026
Hematologic Malignancies: An Overview - Recent Advances
96% match

Hematologic Malignancies: An Overview - Recent Advances

£800.79 02 Oct 2026